tiprankstipranks
Advertisement
Advertisement

PCXELTI Stock Latest News

Xeltis Highlights Dialysis Access Technology at Hamburg Symposium
Private CompaniesXeltis Highlights Dialysis Access Technology at Hamburg Symposium
2h ago
XELTI
Xeltis Highlights Vascular Access Technology at Dialysezugangs Symposium
PremiumPrivate Companies
Xeltis Highlights Vascular Access Technology at Dialysezugangs Symposium
8h ago
XELTI
Xeltis Highlights Upcoming aXess Pivotal Trial Data at CX Symposium
PremiumPrivate Companies
Xeltis Highlights Upcoming aXess Pivotal Trial Data at CX Symposium
1d ago
XELTI
Xeltis Targets Vascular Access Market Visibility With aXess Trial Data at CX Symposium
PremiumPrivate Companies
Xeltis Targets Vascular Access Market Visibility With aXess Trial Data at CX Symposium
1d ago
XELTI
Clinical Publication Highlights Xeltis’ Regenerative Vascular Access Technology
PremiumPrivate Companies
Clinical Publication Highlights Xeltis’ Regenerative Vascular Access Technology
5d ago
XELTI
Xeltis Highlights Decade-Long Research Milestone in Supramolecular Polymer Technology
PremiumPrivate CompaniesXeltis Highlights Decade-Long Research Milestone in Supramolecular Polymer Technology
22d ago
XELTI
Xeltis Expands U.S. Pivotal Trial Sites as It Prepares aXess European Launch
Premium
Private Companies
Xeltis Expands U.S. Pivotal Trial Sites as It Prepares aXess European Launch
23d ago
XELTI
Xeltis Expands U.S. aXess Trial Sites as European Commercial Launch Nears
Premium
Private Companies
Xeltis Expands U.S. aXess Trial Sites as European Commercial Launch Nears
24d ago
XELTI
Xeltis Leadership Engages on U.S. Market Access Strategy at LSX World Congress
PremiumPrivate Companies
Xeltis Leadership Engages on U.S. Market Access Strategy at LSX World Congress
29d ago
XELTI
Xeltis Executive to Discuss U.S. Market Access Strategy at LSX World Congress
PremiumPrivate Companies
Xeltis Executive to Discuss U.S. Market Access Strategy at LSX World Congress
30d ago
XELTI
Xeltis Showcases aXess Vascular Access Conduit as Pivotal Trials Advance
PremiumPrivate Companies
Xeltis Showcases aXess Vascular Access Conduit as Pivotal Trials Advance
1M ago
XELTI
Xeltis Showcases aXess Graft as Pivotal Trials Advance Toward Commercialization
PremiumPrivate Companies
Xeltis Showcases aXess Graft as Pivotal Trials Advance Toward Commercialization
1M ago
XELTI
Xeltis Plans Relocation to High Tech Campus Eindhoven to Support Commercial Scale-Up
PremiumPrivate CompaniesXeltis Plans Relocation to High Tech Campus Eindhoven to Support Commercial Scale-Up
1M ago
XELTI
Xeltis Plans Relocation to High Tech Campus Eindhoven to Support Growth and Commercialization
Premium
Private Companies
Xeltis Plans Relocation to High Tech Campus Eindhoven to Support Growth and Commercialization
1M ago
XELTI
Xeltis Gains Investor-Facing Exposure at BioCapital Europe Cardiovascular Panel
Premium
Private Companies
Xeltis Gains Investor-Facing Exposure at BioCapital Europe Cardiovascular Panel
1M ago
XELTI
Xeltis Showcases Cardiovascular MedTech Focus at BioCapital Europe
PremiumPrivate Companies
Xeltis Showcases Cardiovascular MedTech Focus at BioCapital Europe
1M ago
XELTI
Xeltis Intensifies Conference Outreach as aXess Vascular Access Candidate Nears Commercial Stage
PremiumPrivate Companies
Xeltis Intensifies Conference Outreach as aXess Vascular Access Candidate Nears Commercial Stage
2M ago
XELTI
Xeltis Steps Up Conference Engagement as aXess Advances Toward Commercialization
PremiumPrivate Companies
Xeltis Steps Up Conference Engagement as aXess Advances Toward Commercialization
2M ago
XELTI
Xeltis Advances aXess Hemodialysis Clinical Program With Serbian Trial Site
PremiumPrivate Companies
Xeltis Advances aXess Hemodialysis Clinical Program With Serbian Trial Site
2M ago
XELTI
Xeltis Advances aXess Hemodialysis Clinical Program With Serbian Trial Site
PremiumPrivate CompaniesXeltis Advances aXess Hemodialysis Clinical Program With Serbian Trial Site
2M ago
XELTI
Xeltis Highlights First aXess Implantation at Maastricht University Medical Center
Premium
Private Companies
Xeltis Highlights First aXess Implantation at Maastricht University Medical Center
2M ago
XELTI
Xeltis Highlights First aXess Implantation at Maastricht University Medical Center
Premium
Private Companies
Xeltis Highlights First aXess Implantation at Maastricht University Medical Center
2M ago
XELTI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >